Canine Leptospirosis: Clinical Signs, Diagnosis, and One Health Implications

Introduction

Canine leptospirosis is a globally distributed bacterial zoonosis caused by pathogenic spirochetes of the genus Leptospira. The disease affects multiple organ systems, most notably the kidneys and liver, and can present with acute, subacute, or chronic clinical courses. Transmission occurs through direct contact with urine from infected reservoir hosts or indirectly via contaminated water or soil. The bacterium penetrates mucous membranes or abraded skin, enters the bloodstream, and disseminates to target tissues. More than 250 serovars have been described, with Leptospira interrogans serovars Icterohaemorrhagiae, Canicola, Pomona, and Grippotyphosa being the most frequently implicated in canine disease [1, 2, 3]. The One Health significance of leptospirosis is underscored by its ability to infect humans, livestock, and wildlife, making integrated surveillance and control essential [4, 5, 6].

Clinical Signs

The clinical presentation of canine leptospirosis ranges from subclinical infection to fulminant multi-organ failure. The incubation period is typically 5 to 14 days. Acute leptospirosis is characterized by fever, lethargy, anorexia, vomiting, diarrhea, and muscle pain. As the disease progresses, signs of renal and hepatic dysfunction become evident. Polyuria and polydipsia may precede oliguric or anuric acute kidney injury. Icterus, petechiae, and epistaxis indicate hepatic involvement and coagulopathy. Pulmonary involvement, including leptospiral pulmonary hemorrhage syndrome, has been documented in dogs. Serial evaluation of clinical, functional, and structural pulmonary changes in ten dogs with leptospirosis revealed that pulmonary abnormalities are common and may persist after resolution of systemic signs [7]. Subacute cases may present with milder fever and transient anorexia, while chronic infection can lead to progressive renal fibrosis and protein-losing nephropathy.

Organ System Involvement

Diagnosis

Definitive diagnosis of canine leptospirosis relies on a combination of serological, molecular, and culture-based methods. The microscopic agglutination test (MAT) remains the serological reference standard, detecting antibodies against a panel of serovars. A four-fold rise in titer between acute and convalescent samples or a single titer of 1:800 or higher in a clinically compatible case is considered diagnostic. However, MAT has limitations including cross-reactivity, inability to distinguish between infection and vaccination, and the need for paired samples. Molecular diagnostics, particularly real-time PCR (qPCR) targeting the lipL32 or secY genes, offer high sensitivity and specificity for detecting pathogenic Leptospira DNA in blood, urine, or tissue samples. PCR can detect infection before seroconversion and is especially useful in acute disease. Culture of Leptospira from blood or urine is definitive but slow and requires specialized media.

Comparison of Diagnostic Methods

Recent advances include the development of a recombinant Loa22-gold nanoparticle based lateral flow assay for serodiagnosis of leptospirosis in canine and bovine samples, which offers rapid, equipment-free detection [8]. Additionally, serum sialic acid has been investigated as a biomarker of inflammation and infection in veterinary medicine, with potential utility in monitoring disease severity in leptospirosis [9]. Molecular surveillance using genomic comparison of Leptospira interrogans isolates from humans, dogs, and wild animals provides insights into transmission dynamics and host adaptation [10].

Diagnostic Workflow

graph TD
    A[Clinical suspicion: fever, icterus, azotemia], > B{Acute or convalescent?}
    B, >|Acute (<7 days)| C[Blood qPCR + MAT acute sample]
    B, >|Subacute/chronic| D[Urine qPCR + MAT paired samples]
    C, > E{Results}
    D, > E
    E, >|PCR positive, MAT positive| F[Confirmed leptospirosis]
    E, >|PCR positive, MAT negative| G[Early infection - repeat MAT in 2 weeks]
    E, >|PCR negative, MAT positive| H[Recent infection or vaccination]
    E, >|Both negative| I[Consider alternative diagnoses]
    F, > J[Initiate treatment and report to public health]
    G, > J
    H, > K[Interpret titer level and vaccination history]

Treatment

Antimicrobial therapy should be initiated promptly based on clinical suspicion. Doxycycline (5 mg/kg orally every 12 hours or 10 mg/kg orally every 24 hours for 14 days) is the drug of choice as it eliminates both the acute bacteremic phase and the renal carrier state. Penicillin derivatives (e.g., ampicillin 20 mg/kg intravenously every 6 hours) are alternatives for initial parenteral therapy in severely ill patients, but they do not clear the carrier state. Supportive care includes intravenous fluid therapy to correct dehydration and electrolyte imbalances, antiemetics, hepatoprotectants, and, in cases of acute kidney injury, dialysis may be considered. Blood transfusions may be required for coagulopathy or severe anemia. Serial monitoring of renal and hepatic function is essential to guide therapy and prognosis.

Prevention

Vaccination is the cornerstone of prevention. Multivalent bacterin vaccines containing the most prevalent serovars (e.g., Canicola, Icterohaemorrhagiae, Pomona, Grippotyphosa) are available. Annual revaccination is recommended, although some guidelines suggest more frequent boosters in high-risk areas. Vaccination does not prevent infection but reduces disease severity and shedding. Biosecurity measures include limiting access to stagnant water sources, controlling rodent populations, and isolating infected dogs. In kennel or outbreak settings, risk of infection in dogs in contact with clinical cases is elevated, necessitating prompt identification and prophylactic measures [11].

One Health Implications

Leptospirosis is a classic One Health disease because of its complex ecology involving domestic animals, wildlife, and the environment. Dogs serve as sentinels for human risk, as they share the same environment and exposure sources. Epidemiological studies have demonstrated that meteorological factors such as rainfall and temperature influence the incidence of leptospirosis in both cat and dog populations [4]. In rural areas, livestock farms act as amplification sites, with leptospiral interaction among cattle, dogs, and wildlife [5]. Systematic reviews and meta-analyses have identified risk factors for canine and human leptospirosis in China, including proximity to water bodies and rodent infestation [6]. Serological surveys in indigenous communities in Brazil have revealed high seroprevalence of Leptospira spp. in dogs, highlighting the need for integrated public health interventions [12]. Molecular characterization of an outbreak in Los Angeles County, California, demonstrated the utility of genomic epidemiology in tracing infection sources and informing control measures [1]. In Thailand, pathogenic Leptospira species have been identified in dogs and cats during neutering campaigns, indicating subclinical carriage and potential for zoonotic transmission [2]. Genomic comparison of isolates from humans, dogs, and wild animals in Japan has shown that certain genotypes circulate across species, reinforcing the interconnectedness of transmission cycles [10]. Molecular surveillance in Colombia has detected Leptospira infection in domestic dogs, underscoring the importance of ongoing monitoring in endemic regions [13]. Seroprevalence and molecular epidemiology studies in the Yangtze River region of China have identified serovars and risk factors specific to that geographic area [3].

The zoonotic risk is significant. Humans typically acquire leptospirosis through contact with water or soil contaminated with urine from infected animals. Occupational groups such as veterinarians, farmers, and sewer workers are at increased risk. Public health measures include education on hygiene, use of personal protective equipment, and prompt reporting of suspected cases. The One Health approach advocates for collaborative surveillance across human, animal, and environmental health sectors to detect and control outbreaks early.

Conclusion

Canine leptospirosis remains a diagnostic and therapeutic challenge due to its variable clinical presentation and the diversity of circulating serovars. Advances in molecular diagnostics, including qPCR and genomic sequencing, have improved early detection and epidemiological understanding. Treatment with doxycycline is effective, and vaccination reduces disease burden. The One Health framework is essential for addressing the zoonotic potential of leptospirosis and for implementing integrated control strategies that benefit both animal and human health.

References

[1] Randolph MW, Nally JE, Yoshimoto SK, et al. Clinical and molecular characterization of an outbreak of leptospirosis in dogs from Los Angeles County, California, USA, 2021. J Clin Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42189535/

[2] Thongdee M, Chaiwattanarungruengpaisan S, Paungpin W, et al. Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/41637464/

[3] Ding Y, Zhang S, Zhang W, et al. Seroprevalence and Molecular Epidemiology of Leptospira spp. Infecting Dogs in the Yangtze River Region of China. Transbound Emerg Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/41383393/

[4] Hobson SJ, Zai B, Vyn CM, et al. Impacts of meteorological factors on zoonotic infections in domestic cat and dog populations: A scoping review of international evidence. One Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42211529/

[5] Patiño-Gómez S, Naranjo-Vargas LF, Aguirre-Acevedo DC, et al. Epidemiological study of leptospiral interaction in bovine farms in rural areas of Colombia: A One Health approach. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42090421/

[6] Wei W, Jiao D, Dong X, et al. Epidemiology and associated factors of human and canine leptospirosis in China: a systematic review and meta-analysis. Prev Vet Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41864068/

[7] Bringold C, Schweighauser A, Walther S, et al. Serial evaluation of clinical, functional, and structural pulmonary changes in 10 dogs with leptospirosis. J Vet Intern Med. 2026. https://pubmed.ncbi.nlm.nih.gov/42224492/

[8] Gautam H, Kumar BVS, Singh S, et al. Evaluation of a recombinant Loa22-gold nanoparticle based lateral flow assay for the serodiagnosis of leptospirosis in canine and bovine. Arch Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41524783/

[9] Yaghoobpour T, Faraji M, Nazifi S. Serum Sialic Acid as a Biomarker of Inflammation and Infection: Insights From Veterinary Medicine. Vet Med Int. 2026. https://pubmed.ncbi.nlm.nih.gov/42148179/

[10] Kakita T, Takabe K, Morita M, et al. Genomic comparison of Leptospira interrogans isolated from humans, dogs, and wild and feral animals in Japan. Int J Med Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41579465/

[11] Skinner VJ, Ward MP, Griebsch C. Risk of infection in dogs in contact with clinical canine leptospirosis cases. Aust Vet J. 2026. https://pubmed.ncbi.nlm.nih.gov/41814781/

[12] Galvão CMMQ, Leite DPSBM, Oliveira PRF, et al. First serological investigation of Toxoplasma gondii, Neospora caninum, Leishmania infantum and Leptospira spp. in dogs from a Fulni-ô Indigenous community in Pernambuco, Brazil: a One Health perspective. Braz J Biol. 2026. https://pubmed.ncbi.nlm.nih.gov/41849483/

[13] Beltrán-Sánchez CA, Bettin AC, Castellanos-Romero K, et al. Molecular surveillance of Leptospira infection in domestic dogs in Soledad, Northern Colombia. Vet Res Commun. 2026. https://pubmed.ncbi.nlm.nih.gov/41557245/

[14] Gupta S, Matsunaga J, Ratitong B, et al. cGAS-STING dependent type I IFN reduces Leptospira interrogans renal colonization in mice. PLoS Pathog. 2026. https://pubmed.ncbi.nlm.nih.gov/41499635/

[15] Decoster C, Lefère L, Raes E, et al. Equine leptospiral pulmonary haemorrhage syndrome: An atypical manifestation of equine leptospirosis. Equine Vet J. 2026. https://pubmed.ncbi.nlm.nih.gov/41451997/